Browsing

Stock Exchange

TCR2 Therapeutics Announces Pricing of IPO of Common Stock

BioStartups Feb 19, 2019

TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T-cell receptor (TCR) therapies for patients suffering from cancer. It…

Stock exchange PR

Gossamer Bio, Inc. Announces Pricing of Initial Public Offering

BioStartups Feb 11, 2019

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology,…